LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agents-Reference-Cited by-同舟云学术

LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agents

Published:2020-02-08 Issue:6 Volume:61 Page:1493-1499
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Chien Kelly S.¹^ORCID,Class Caleb A.²^ORCID,Montalban-Bravo Guillermo³,Wei Yue³,Sasaki Koji³,Naqvi Kiran³,Ganan-Gomez Irene³,Yang Hui³,Soltysiak Kelly A.³,Kanagal-Shamanna Rashmi⁴^ORCID,Do Kim-Anh²^ORCID,Kantarjian Hagop M.³,Garcia-Manero Guillermo³

Affiliation:

1. Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

2. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

3. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

4. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1723014

Reference20 articles.

1. HLA-G

2. Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors

3. Soluble Ig-Like Transcript 3 Inhibits Tumor Allograft Rejection in Humanized SCID Mice and T Cell Responses in Cancer Patients

4. Recombinant Ig-Like Transcript 3-Fc Modulates T Cell Responses via Induction of Th Anergy and Differentiation of CD8+ T Suppressor Cells

5. Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T Cells in Acute Myeloid Leukemia: Where Do We Stand?;Biomedicines;2024-05-28

2. Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome‑refractory anemia by regulating the cell cycle;Experimental and Therapeutic Medicine;2023-10-26

3. Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia;Current Treatment Options in Oncology;2023-06-10

4. Optimizing Treatment Options for Newly Diagnosed Acute Myeloid Leukemia in Older Patients with Comorbidities;Cancers;2023-04-21

5. Current Understanding of DDX41 Mutations in Myeloid Neoplasms;Cancers;2023-01-05